Dr. Alexander MacKenzie recognized by PCC for excellence and leadership in pediatrics
Dr. Alexander MacKenzie has been recently recognized by the Pediatric Chairs of Canada (PCC) for his excellence and leadership as a clinician investigator in the field of pediatrics.
On June 2, Dr. MacKenzie was announced as this year’s recipient of the 2017 Pediatric Academic Leadership - Clinician Investigator Award. The recognition is one of three annual academic leadership awards bestowed by the PCC, who have been presenting to the most worthy candidates since 2007 as selected by their peers.
PCC believes that “the health of children and youth is dependent on leadership in each of the roles of clinician practitioner, clinician educator, and clinician investigator, all with the provision of administrative leadership.” The organization praised Dr. MacKenzie’s impressive career including 27 years as clinician investigator, remarking that in addition to “demonstrating, and promoting, academic excellence through critical leadership roles, his scholarly work has been recognized nationally and internationally.”
A professor in the Department of Pediatrics at the University of Ottawa Faculty of Medicine, Dr. MacKenzie specializes in spinal muscular atrophy and publishes in the area of molecular genetics of pediatric disease. He was Scientific Director and CEO of the CHEO Research Institute for 11 years, and played a key role in the significant recruitment and development of new investigator research at CHEO.
Department Chair Dr. Ciarán Duffy submitted Dr. MacKenzie’s nomination, saying “There is no doubt that Alex MacKenzie has been a clinician investigator of the highest quality, but he has played an absolutely pivotal role in the development, growth and current success of the CHEO Research Institute.”
The awards will be presented at PCC’s dinner meeting in October.
Read more about Dr.MacKenzie’s merit in achieving this recognition.